Who We Are
MolecularMD Provides Clients with a Full-service Diagnostics Offering Designed to Accelerate Oncology Drug Approval
MolecularMD (MMD) streamlines the co-development and commercialization of molecular diagnostic tests that are deployed and leveraged across the continuum of the drug development process. Our capabilities are broad with significant scientific capabilities, which include:
- Assay design and development services
- Sample banking and bridging strategies
- Clinical trial design
- Regulatory planning
- Analytical and clinical assay validation
- Full-service histology and pathology offerings; including immunohistochemistry (IHC) assay development
- FDA submission services
- Custom clinical GMP kit manufacturing.
MMD works with its clients to manage risks and optimize their ROI by providing flexible, platform-agnostic diagnostic services, an uncommon approach and one that is not well served by contract research organizations (CROs) or in-vitro diagnostic platform providers. For over 10 years, the company has developed an exceptional reputation among both industry and FDA regulatory leaders.
Learn more about MolecularMD’s unique capabilities.